Cargando…

Rituximab in the Treatment of Interstitial Lung Disease Associated with Autoimmune Diseases: Experience from a Single Referral Center and Literature Review

In the present study, we aimed to report our experience with rituximab (RTX) in the treatment of patients with ILD associated with AD (AD-ILD) at a single center. For this purpose, clinical characteristics, radiological findings, and pulmonary function tests (PFTs) of RTX-treated AD-ILD-patients see...

Descripción completa

Detalles Bibliográficos
Autores principales:	Atienza-Mateo, Belén, Remuzgo-Martínez, Sara, Prieto-Peña, Diana, Mora Cuesta, Víctor Manuel, Iturbe-Fernández, David, Llorca, Javier, Sánchez-Bilbao, Lara, Corrales, Alfonso, Blanco Rodríguez, Gerardo, Gómez-Román, José Javier, Cifrián, José Manuel, González-Gay, Miguel Ángel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598697/ https://www.ncbi.nlm.nih.gov/pubmed/32977717 http://dx.doi.org/10.3390/jcm9103070

Ejemplares similares

The Spectrum of Interstitial Lung Disease Associated with Autoimmune Diseases: Data of a 3.6-Year Prospective Study from a Referral Center of Interstitial Lung Disease and Lung Transplantation †
por: Atienza-Mateo, Belén, et al.
Publicado: (2020)

Angiogenic T Cells: Potential Biomarkers for the Early Diagnosis of Interstitial Lung Disease in Autoimmune Diseases?
por: Pulito-Cueto, Verónica, et al.
Publicado: (2022)

Endothelin-1 as a Biomarker of Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Associated with Autoimmune Diseases
por: Pulito-Cueto, Verónica, et al.
Publicado: (2023)

E-Selectin, ICAM-1, and ET-1 Biomarkers Address the Concern of the Challenging Diagnosis of Interstitial Lung Disease in Patients with Autoimmune Diseases
por: Pulito-Cueto, Verónica, et al.
Publicado: (2023)

Endothelial Progenitor Cells as a Potential Biomarker in Interstitial Lung Disease Associated with Rheumatoid Arthritis
por: Pulito-Cueto, Verónica, et al.
Publicado: (2020)

Endothelial Progenitor Cells: Relevant Players in the Vasculopathy and Lung Fibrosis Associated with the Presence of Interstitial Lung Disease in Systemic Sclerosis Patients
por: Pulito-Cueto, Verónica, et al.
Publicado: (2021)

Role of VEGF Polymorphisms in the Susceptibility and Severity of Interstitial Lung Disease
por: Remuzgo-Martínez, Sara, et al.
Publicado: (2021)

Elevated VCAM-1, MCP-1 and ADMA serum levels related to pulmonary fibrosis of interstitial lung disease associated with rheumatoid arthritis
por: Pulito-Cueto, Verónica, et al.
Publicado: (2022)

Atypical presentation of immunoglobulin G4-related disease as subglottic stenosis: a case-based review
por: Atienza-Mateo, Belén, et al.
Publicado: (2021)

Misperception of the Cardiovascular Risk in Patients with Rheumatoid Arthritis
por: Alonso-Molero, Jéssica, et al.
Publicado: (2020)

Double-Lung Transplantation in a Patient with Pulmonary Type B Niemann-Pick Disease: A Valid Treatment Option
por: Mora, Víctor Manuel, et al.
Publicado: (2022)

The Performance of Vascular Age in the Assessment of Cardiovascular Risk of Patients with Rheumatoid Arthritis
por: Ferraz-Amaro, Iván, et al.
Publicado: (2020)

Cranial and extracranial giant cell arteritis do not have different HLA-DRB1 and HLA-B association in Caucasian individuals
por: Prieto-Peña, Diana, et al.
Publicado: (2021)

Rituximab-associated interstitial lung disease in fibrillary glomerulonephritis
por: Sainz-Prestel, Valeria, et al.
Publicado: (2013)

Moderate and High Disease Activity Predicts the Development of Carotid Plaque in Rheumatoid Arthritis Patients without Classic Cardiovascular Risk Factors: Six Years Follow-Up Study
por: Ferraz-Amaro, Iván, et al.
Publicado: (2021)

A Proof-of-Concept Analysis of Plasma-Derived Exosomal microRNAs in Interstitial Pulmonary Fibrosis Secondary to Antisynthetase Syndrome
por: Bozzini, Sara, et al.
Publicado: (2022)

Interstitial lung disease in patients with scleroderma - Treatment with rituximab
por: Muñoz, A, et al.
Publicado: (2010)

Exacerbation of chronic renal failure because of inhaled tobramycin in a lung transplant patient
por: Mora Cuesta, Víctor M., et al.
Publicado: (2022)

Role of MUC1 rs4072037 polymorphism and serum KL-6 levels in patients with antisynthetase syndrome
por: Remuzgo-Martínez, Sara, et al.
Publicado: (2021)

Rituximab for the treatment of acute exacerbation of interstitial lung disease associated with connective tissue disease
por: León Román, Francisco, et al.
Publicado: (2023)

Expression of osteoprotegerin and its ligands, RANKL and TRAIL, in rheumatoid arthritis
por: Remuzgo-Martínez, Sara, et al.
Publicado: (2016)

Rituximab-induced interstitial lung disease: five case reports
por: Naqibullah, Matiuallah, et al.
Publicado: (2015)

A rare case of rituximab induced interstitial lung disease
por: Sahu, Kamal Kant, et al.
Publicado: (2016)

Rituximab treatment in patients with systemic sclerosis and interstitial lung disease
por: Mohammed, Abdel Gaffar A., et al.
Publicado: (2017)

Interstitial Lung Disease and Anti-Myeloperoxidase Antibodies: Not a Simple Association
por: Sebastiani, Marco, et al.
Publicado: (2021)

Disease activity influences the reclassification of rheumatoid arthritis into very high cardiovascular risk
por: Ferraz-Amaro, Iván, et al.
Publicado: (2021)

Efficacy and Safety of Rituximab in Autoimmune Disease—Associated Interstitial Lung Disease: A Prospective Cohort Study
por: Mena-Vázquez, Natalia, et al.
Publicado: (2022)

A Case of Interstitial Lung Disease Probably Related to Rituximab Treatment
por: Calderazzo, Massimo, et al.
Publicado: (2015)

Calcineurin inhibitors’ impact on cardiovascular and renal function, a descriptive study in lung transplant recipients from the North of Spain
por: Nogueiras-Álvarez, Rita, et al.
Publicado: (2022)

Efficacy and safety of rituximab in the treatment of connective tissue disease-related interstitial lung disease
por: Vacchi, Caterina, et al.
Publicado: (2021)

Association of circulating calprotectin with lipid profile in axial spondyloarthritis
por: Genre, Fernanda, et al.
Publicado: (2018)

Author Correction: BAFF, APRIL and BAFFR on the pathogenesis of Immunoglobulin-A vasculitis
por: Prieto-Peña, Diana, et al.
Publicado: (2021)

BAFF, APRIL and BAFFR on the pathogenesis of Immunoglobulin-A vasculitis
por: Prieto-Peña, Diana, et al.
Publicado: (2021)

A Review of the Dermatological Complications of Giant Cell Arteritis
por: Prieto-Peña, Diana, et al.
Publicado: (2021)

Rituximab in Antimelanoma Differentiation-Associated Protein-5 Dermatomyositis with Interstitial Lung Disease
por: Scirocco, Chiara, et al.
Publicado: (2020)

Rituximab-Induced Interstitial Lung Disease: A Stitch in Time Saved Nine
por: Tej, Sai, et al.
Publicado: (2022)

Lack of concordance between the different exercise test measures used in the risk stratification of patients with pulmonary arterial hypertension
por: Mora Cuesta, Víctor M., et al.
Publicado: (2022)

Rituximab Versus Mycophenolate in the Treatment of Recalcitrant Connective Tissue Disease–Associated Interstitial Lung Disease
por: Zhu, Lisa, et al.
Publicado: (2020)

Pulmonary rehabilitation for interstitial lung disease: Referral and patient experiences
por: Hoffman, Mariana, et al.
Publicado: (2021)

Role of the IL33 and IL1RL1 pathway in the pathogenesis of Immunoglobulin A vasculitis
por: Prieto-Peña, Diana, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3scaf6u3o4ptm02nmbauo9qjl8